Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone cells and matrix bind chemically modified non-antimicrobial tetracycline

T Sasaki1, N S Ramamurthy, L M Golub

  • 1Second Department of Oral Anatomy, School of Dentistry, Showa University, Tokyo, Japan.

Bone
|May 1, 1994
PubMed
Summary

Chemically modified tetracycline (CMT) binds to osteogenic cells and bone matrix in neonatal rats. This non-antimicrobial compound is rapidly metabolized by these bone-forming cells.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In Vivo Assay of Crevicular Leukocyte Migration: Its Development and Potential Applications.

Journal of periodontology·2018
Same author

Tetracyclines Inhibit Tissue Collagenases: Effects of Ingested Low-Dose and Local Delivery Systems.

Journal of periodontology·2018
Same author

A novel chemically modified curcumin reduces inflammation-mediated connective tissue breakdown in a rat model of diabetes: periodontal and systemic effects.

Journal of periodontal research·2016
Same author

Serum bone biomarkers and oral/systemic bone loss in humans.

Journal of dental research·2011
Same author

Doxycycline effects on serum bone biomarkers in post-menopausal women.

Journal of dental research·2010
Same author

Can systemic diseases co-induce (not just exacerbate) periodontitis? A hypothetical "two-hit" model.

Journal of dental research·2006

Area of Science:

  • Biochemistry
  • Cell Biology
  • Orthopedics

Background:

  • Tetracyclines are known for their antimicrobial properties and ability to bind to bone mineral.
  • The behavior of chemically modified, non-antimicrobial tetracyclines in bone tissue is less understood.
  • Investigating the cellular and matrix interactions of modified tetracyclines is crucial for potential therapeutic applications.

Purpose of the Study:

  • To investigate the localization and binding of a chemically modified, non-antimicrobial tetracycline (CMT) in neonatal rat calvariae.
  • To determine the cellular uptake and metabolic fate of CMT in osteogenic cells.
  • To differentiate CMT binding to bone mineral versus osteogenic cells.

Main Methods:

  • Intraperitoneal injection of 3H-labeled CMT into neonatal rats.

Related Experiment Videos

  • Tissue collection at 20 minutes, 2 hours, and 4 hours post-injection.
  • Localization of 3H-CMT binding using light and electron microscopic autoradiography in calvariae.

    • Main Results:

    • High levels of 3H-CMT were found in periosteal cells (osteoblasts, preosteoblasts) and newly formed bone matrix at 20 minutes.
    • Ultrastructural analysis showed 3H-CMT associated with osteoblast cytoplasm and plasma membranes.
    • Cellular 3H-CMT levels decreased significantly by 2-4 hours, while bone matrix labeling remained stable.

    Conclusions:

    • CMT directly binds to or is taken up by osteogenic cells, in addition to binding to the bone mineral phase.
    • Osteogenic cells rapidly metabolize CMT.
    • These findings suggest a distinct cellular interaction mechanism for CMT beyond simple mineral binding.